Archives of Clinical Infectious Diseases

Published by: Kowsar

Clinical and Mycological Study of Vulvovaginal Candidiasis (VVC); Identification of Clinical Isolates by Polymerase Chain Reaction-Fragment Size Polymorphyim (PCR-FSP) Technique

Shekufeh Pouladian 1 , Minoo Movahedi 2 and Rasoul Mohammadi 1 , 3 , *
Authors Information
1 Department of Medical Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran
3 Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • Archives of Clinical Infectious Diseases: April 2017, 12 (2); e62761
  • Published Online: April 30, 2017
  • Article Type: Research Article
  • Received: January 9, 2017
  • Revised: March 13, 2017
  • Accepted: April 9, 2017
  • DOI: 10.5812/archcid.62761

To Cite: Pouladian S, Movahedi M, Mohammadi R. Clinical and Mycological Study of Vulvovaginal Candidiasis (VVC); Identification of Clinical Isolates by Polymerase Chain Reaction-Fragment Size Polymorphyim (PCR-FSP) Technique, Arch Clin Infect Dis. 2017 ; 12(2):e62761. doi: 10.5812/archcid.62761.

Abstract
Copyright © 2017, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnote
References
  • 1. Mohamadi J, Havasian MR, Panahi J, Pakzad I. Antifungal drug resistance pattern of Candida. spp isolated from vaginitis in Ilam-Iran during 2013-2014. Bioinformation. 2015; 11(4): 203-6[DOI][PubMed]
  • 2. Lisiak M, Klyszejko C, Pierzchalo T, Marcinkowski Z. [Vaginal candidiasis: frequency of occurrence and risk factors]. Ginekol Pol. 2000; 71(9): 964-70[PubMed]
  • 3. Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol Reprod Biol. 2006; 126(1): 121-5[DOI][PubMed]
  • 4. Barousse MM, Espinosa T, Dunlap K, Fidel PJ. Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect Immun. 2005; 73(11): 7765-7[DOI][PubMed]
  • 5. Seifi Z, Zarei Mahmoudabadi A, Zarrin M. Extracellular enzymes and susceptibility to fluconazole in Candida strains isolated from patients with vaginitis and healthy individuals. Jundishapur J Microbiol. 2015; 8(3)[DOI][PubMed]
  • 6. Sekhavat L, Tabatabaii A, Tezerjani FZ. Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. J Infect Public Health. 2011; 4(4): 195-9[DOI][PubMed]
  • 7. Marchaim D, Lemanek L, Bheemreddy S, Kaye KS, Sobel JD. Fluconazole-resistant Candida albicans vulvovaginitis. Obstet Gynecol. 2012; 120(6): 1407-14[PubMed]
  • 8. Silva GAD, Bernardi TL, Schaker PDC, Menegotto M, Valente P. Rapid yeast DNA extraction by boiling and freeze-thawing without using chemical reagents and DNA purification. Braz Arch Biol Technol. 2012; 55(2): 319-27[DOI]
  • 9. Mohammadi R, Mirhendi H, Yadegari MH, Ghahri M, Shadzi S, Jalalizand N. Evaluation of pevalence of the new Candida species (C. Orthopsilosis and C. Metapsilosis) among C. Parapsilosis group isolated from patients by PCR-RFLP of SADH gene in Iran [In Persian]. J Isfahan Med Sch. 2011; 29(134): 1-10
  • 10. Mohammadi R, Abastabar M, Mirhendi H, Badali H, Shadzi S, Chadeganipour M, et al. Use of Restriction Fragment Length Polymorphism to Rapidly Identify Dermatophyte Species Related to Dermatophytosis. Jundishapur J Microbiol. 2015; 8(6)[DOI][PubMed]
  • 11. White TJ, Bruns T, Lee S, Taylor J. PCR protocols: a guide to methods and applications. 1990; 18: 315-22[DOI]
  • 12. Staniszewska M, Bondaryk M, Pilat J, Siennicka K, Magda U, Kurzatkowski W. [Virulence factors of Candida albicans]. Przegl Epidemiol. 2012; 66(4): 629-33[PubMed]
  • 13. Hofs S, Mogavero S, Hube B. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota. J Microbiol. 2016; 54(3): 149-69[DOI][PubMed]
  • 14. Biswas S, Van Dijck P, Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiol Mol Biol Rev. 2007; 71(2): 348-76[DOI][PubMed]
  • 15. Aguin TJ, Sobel JD. Vulvovaginal candidiasis in pregnancy. Curr Infect Dis Rep. 2015; 17(6): 462[DOI][PubMed]
  • 16. Ebrahimy F, Dolatian M, Moatar F, Majd HA. Comparison of the therapeutic effects of Garcin((R)) and fluconazole on Candida vaginitis. Singapore Med J. 2015; 56(10): 567-72[DOI][PubMed]
  • 17. Hong E, Dixit S, Fidel PL, Bradford J, Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis. 2014; 18(1): 31-8[DOI][PubMed]
  • 18. Martins HP, da Silva MC, Paiva LC, Svidzinski TI, Consolaro ME. Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species. Acta Derm Venereol. 2012; 92(1): 78-82[DOI][PubMed]
  • 19. Esim Buyukbayrak E, Kars B, Karsidag AY, Karadeniz BI, Kaymaz O, Gencer S, et al. Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis. Arch Gynecol Obstet. 2010; 282(5): 515-9[DOI][PubMed]
  • 20. Dan M, Kaneti N, Levin D, Poch F, Samra Z. Vaginitis in a gynecologic practice in Israel: causes and risk factors. Isr Med Assoc J. 2003; 5(9): 629-32[PubMed]
  • 21. Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009; 144(1): 68-71[DOI][PubMed]
  • 22. Dai Q, Hu L, Jiang Y, Shi H, Liu J, Zhou W, et al. An epidemiological survey of bacterial vaginosis, vulvovaginal candidiasis and trichomoniasis in the Tibetan area of Sichuan Province, China. Eur J Obstet Gynecol Reprod Biol. 2010; 150(2): 207-9[DOI][PubMed]
  • 23. Hay P, Czeizel AE. Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007; 21(3): 403-9[DOI][PubMed]
  • 24. Mtibaa L, Fakhfakh N, Kallel A, Belhadj S, Belhaj Salah N, Bada N, et al. Vulvovaginal candidiasis: Etiology, symptomatology and risk factors. J Mycol Med. 2017; 27(2): 153-8[DOI][PubMed]
  • 25. Masri SN, Noor SM, Nor LA, Osman M, Rahman MM. Candida isolates from pregnant women and their antifungal susceptibility in a Malaysian tertiary-care hospital. Pak J Med Sci. 2015; 31(3): 658-61[DOI][PubMed]
  • 26. Mucci MJ, Cuestas ML, Cervetto MM, Landaburu MF, Mujica MT. A prospective observational study of vulvovagintis in pregnant women in Argentina, with special reference to candidiasis. Mycoses. 2016; 59(7): 429-35[DOI][PubMed]
  • 27. Nnadi DC, Singh S. The prevalence of genital Candida species among pregnant women attending antenatal clinic in a tertiary health center in North-west Nigeria. Sahel Med J. 2017; 20(1): 33-7
  • 28. Mohammadi R, Nazeri M, Mesdaghinia E, Mirhendi SH. Identification of Candida species among patients with vulvovaginal Candidiasis in Kashan by PCR-RFLP method [In Persian]. J Isfahan Med Sch. 2012; 29(165): 2-8
  • 29. Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010; 23(2): 253-73[DOI][PubMed]
  • 30. Ismail AM, Abbas AM, Shams AH, Kamel MA, Makarem MH. The effect of use of vaginal Lactobacillus Rhamnosus for prevention of recurrence of vulvovaginal candidiasis; A randomized controlled trial. Thai J Obstet Gynaecol. 2017; 25(1): 62-8[DOI]
  • 31. Raphaelids L. Idiopathic recurrent vulvovaginal Candidiasis. J Nurse Pract. 2017; 13(2): 178-9[DOI]
  • 32. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000; 27(4): 230-5[DOI][PubMed]
  • 33. Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012; 66: 371-89[DOI][PubMed]
  • 34. Peters BM, Yano J, Noverr MC, Fidel PJ. Candida vaginitis: when opportunism knocks, the host responds. PLoS Pathog. 2014; 10(4)[DOI][PubMed]
  • 35. Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Yazdani Cherati J, Mosayebi E. Isolation of different species of Candida in patients with vulvovaginal candidiasis from sari, iran. Jundishapur J Microbiol. 2015; 8(4)[DOI][PubMed]
  • 36. Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. Eur J Obstet Gynecol Reprod Biol. 2011; 155(2): 199-203[DOI][PubMed]
  • 37. Asadi MA, Rasti S, Arbabi M, Hooshyar H, Yoosefdoost H. Prevalence of vaginal Candidiasis in married women referred to Kashan's health centers, 1993-94 [In Persian]. Kashan Univers Med Sci J. 1997; 1(1): 21-7
  • 38. Yusuf MA, Chowdhury MAQ, Sattar ANI, Rahman MM. Evaluation of the Effect of Contraceptives on Prevalence of Candida Species on Vaginal Candidiasis in Dhaka, Bangladesh. Bangladesh J Med Microbiol. 2016; 1(2): 61-4[DOI]
  • 39. Dharmik PG, Gomashe AV, Upadhyay VG. Susceptibility pattern of various azoles against Candida species causing vulvovaginal candidiasis. J Obstet Gynaecol India. 2013; 63(2): 135-7[DOI][PubMed]
  • 40. Dou N, Li W, Zhao E, Wang C, Xiao Z, Zhou H. Risk factors for candida infection of the genital tract in the tropics. Afr Health Sci. 2014; 14(4): 835-9[DOI][PubMed]
  • 41. Mukasa KJ, Herbert I, Daniel A, Sserunkuma KL, Joel B, Frederick B. Antifungal Susceptibility Patterns of Vulvovaginal Candida species among Women Attending Antenatal Clinic at Mbarara Regional Referral Hospital, South Western Uganda. 2015; 5(4): 322-31[DOI][PubMed]
  • 42. Mahmoudabadi AZ, Najafyan M, Alidadi M. Clinical study of Candida vaginitis in Ahvaz, Iran and susceptibility of agents to topical antifungal. Pak J Med Sci. 2010; 26(3): 607-10
  • 43. Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: Comparison of single and sequential doses of fluconazole. Obstet Gynecol Sur. 2002; 57(1): 26-7[DOI]
  • 44. Kennedy MA, Sobel JD. Vulvovaginal Candidiasis Caused by Non-albicans Candida Species: New Insights. Curr Infect Dis Rep. 2010; 12(6): 465-70[DOI][PubMed]
  • 45. Jamilian M, Mashadi E, Sarmadi F, Banijamali M, Farhadi E, Ghanatpishe E. Frequancy of vulvovaginal Candidiasis species in nonpregnant 15-50 years old women in spring 2005 in Arak [In Persian]. Arak Med Uni J. 2007; 10(2): 7-14
  • 46. Lopes Consolaro ME, Aline Albertoni T, Shizue Yoshida C, Mazucheli J, Peralta RM, Estivalet Svidzinski TI. Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringa, Parana, Brazil. Rev Iberoam Micol. 2004; 21(4): 202-5[PubMed]
  • 47. Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol. 1998; 178(2): 203-11[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments